Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1)

[Edit]

MIR1; MID1-related protein 1; Microtubule-associated protein GLFND

Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1)
FSD1 encodes a centrosome associated protein that is characterized by an N-terminal coiled-coil region downstream of B-box (BBC) domain, a central fibronectin type III domain, and a C-terminal repeats in splA and RyR (SPRY) domain. The encoded protein associates with a subset of microtubules and may be involved in the stability and organization of microtubules during cytokinesis.
FSD1 shares 92% amino acid identity with mouse Fsd1 and significant similarity with its bovine and porcine paralogs. It also shares significant similarity with FSD1NL. Northern blot analysis of several human tissues detected abundant expression of a major 1.8- to 2.0-kb transcript and minor 3.0- and 3.5-kb transcripts in brain only.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Fibronectin Type III And SPRY Domain Containing Protein 1 (FSD1) ELISA Kit Customized Service Offer
  1. "Characterization of human FSD1, a novel brain specific gene on chromosome 19 with paralogy to 9q31."Biochim. Biophys. Acta 1518:200-203(2001) [PubMed] [Europe PMC] [Abstract]
  2. "Identification of a novel microtubule-associated protein that regulates microtubule organization and cytokinesis by using a GFP-screening strategy."Curr. Biol. 12:1946-1951(2002) [PubMed] [Europe PMC] [Abstract]
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "A novel centrosome-associated protein with affinity for microtubules."J. Cell Sci. 115:3389-3402(2002) [PubMed] [Europe PMC] [Abstract]
  6. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]